Diomed boosts sales force to meet demand:
This article was originally published in Clinica
Executive Summary
Diomed is to substantially increase its US sales force in order to meet demand for its endovenous laser treatment (EVLT) for varicose veins. The Andover, Massachusetts company's product works by closing the greater saphenous vein, which allows the branch veins to shrink. The company claims its technique results in shorter recovery times, higher success rates, lack of scarring, lower cost and greater convenience when compared with conventional vein stripping.
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.